Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inadequate Glucose Control”

339 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 339 results

Large-scale testing (Phase 3)UnknownNCT04667143
What this trial is testing

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy

Who this might be right for
Diabetes Mellitus, Type II
Jiangsu HengRui Medicine Co., Ltd. 760
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07239440
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Who this might be right for
Diabete Mellitus
Dong-A ST Co., Ltd. 288
Large-scale testing (Phase 3)Study completedNCT01422876
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,405
Early research (Phase 1)Study completedNCT02582840
What this trial is testing

The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

Who this might be right for
Type 1 Diabetes Mellitus
AstraZeneca 42
Large-scale testing (Phase 3)Study completedNCT01316107
What this trial is testing

Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients

Who this might be right for
Type 2 Diabetes Mellitus
Astellas Pharma Inc 122
Large-scale testing (Phase 3)Study completedNCT02229383
What this trial is testing

Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
AstraZeneca 464
Large-scale testing (Phase 3)Study completedNCT05814406
What this trial is testing

To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM

Who this might be right for
Type 2 Diabetes Mellitus
JW Pharmaceutical 196
Large-scale testing (Phase 3)Study completedNCT00528372
What this trial is testing

A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise

Who this might be right for
Type 2 Diabetes
AstraZeneca 1,067
Post-approval studies (Phase 4)UnknownNCT02919059
What this trial is testing

Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.

Who this might be right for
Diabetes Mellitus, Type 2
IInstituto Gallego de Medicina Vascular 159
Large-scale testing (Phase 3)Study completedNCT01177813
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 986
Large-scale testing (Phase 3)Study completedNCT01031680
What this trial is testing

Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension

Who this might be right for
Type 2 Diabetes MellitusCardiovascular DiseaseHypertension+1 more
AstraZeneca 922
Large-scale testing (Phase 3)Study completedNCT02926937
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy

Who this might be right for
Type 2 Diabetes Mellitus
Lexicon Pharmaceuticals 399
Large-scale testing (Phase 3)Study completedNCT00162240
What this trial is testing

PPAR - Combination With Metformin

Who this might be right for
Diabetes Mellitus
Bristol-Myers Squibb 534
Large-scale testing (Phase 3)Study completedNCT01009580
What this trial is testing

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 447
Large-scale testing (Phase 3)Study completedNCT01189890
What this trial is testing

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 480
Large-scale testing (Phase 3)Study completedNCT01682759
What this trial is testing

The Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 751
Post-approval studies (Phase 4)Study completedNCT00913367
What this trial is testing

Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Handok Inc. 110
Large-scale testing (Phase 3)Study completedNCT01755156
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 402
Large-scale testing (Phase 3)Study completedNCT01076075
What this trial is testing

Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 427
Testing effectiveness (Phase 2)Study completedNCT05666128
What this trial is testing

Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus
Hyundai Pharm 112
Next Page